News FDA cracks down on bogus cell therapy firms The FDA’s commissioner Scott Gottlieb has pledged to crack down on “unscrupulous actors” attempting to treat patients with potentially dangerous or unproven stem cell therapies.
News J&J speaks out as old drug included in lethal injection State of Florida to use untried cocktail in execution of Mark Asay
News Pharma welcomes UK's post-Brexit trade plans UK pharma and biotech trade bodies have welcomed government proposals to ensure trade and services can continue after Brexit in March 2019.
News US opioid crisis a 'national emergency', says Trump Declaration means potential more resources and power to states and federal agencies.
News FDA advisers reject J&J rheumatoid arthritis drug Expert panel concerned about safety of sirukumab.
News Ambrosia's sweet $100m round, and other biofinancings Our latest crop of biofinancings has a nine-figure round for Ambrosia, with Pinnacle Medicines, Immutrin, and Gilgamesh Pharma also raising new funds.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.